Work

Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug

Year: 2003

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-003-0580-5

Authors: Martin J. Edelman, Kenneth Bauer, Shyam Khanwani, Nancy Tait, Jane Trepel, Judith Karp, Noble Nemieboka, Eun-Joo Chung, David Van Echo

Institutions: VA Maryland Health Care System, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G3085657980, PHASE I TRIALS OF ANTICANCER AGENTS

OpenAlex ID: W1600365595

FWCI: 1.072

Cites: 17

Cited by: 93

Related to: 10